Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities
- 6 March 2015
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 56 (9) , 2552-2555
Abstract
The serum albumin (SA) level has been reported to be an independent prognostic biomarker that may serve as a surrogate representative of disease biology in patients diagnosed with myelodysplastic syndrome (MDS). However, its prognostic ability has not been tested in a model adjusting for comorbidities. We analyzed 200 patients who were diagnosed as having de novo MDS. Median overall survival (OS) of all patients was 25 months and median leukemia-free survival (LFS) was 24 months. Median OS according to the SA level groups of ≤ 3.5, 3.6–4.0 and > 4.0 mg/dL were 24, 39 and 77 months, respectively. SA level remained an independent predictor of both LFS and OS even when adjusting for the hematopoietic cell transplant comorbidity index (HCT-CI) and the International Prognostic Scoring System (IPSS) or World Health Organization classification-based Prognostic Scoring System (WPSS). Our findings indicate that SA level at the time of diagnosis is a significant and independent predictor of LFS and OS even when adjusting for commonly used prognostic systems and comorbidities.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletionTherapeutic Advances in Hematology, 2012
- Low preoperative serum albumin in colon cancer: a risk factor for poor outcomeInternational Journal of Colorectal Disease, 2010
- Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeHaematologica, 2010
- Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study GroupAnnals of Oncology, 2009
- Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndromeHaematologica, 2009
- The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndromeHaematologica, 2009
- Pre-operative hypoalbuminemia is a major risk factor for postoperative complications following rectal cancer surgeryWorld Journal of Gastroenterology, 2008
- Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiencesBlood, 2007
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987